BIO logo

BIO EBITDA Margin

Latest reported19.88%
BIO TTM EBITDA Margin (17.89% → 19.88%)
High-resolution chart · PNG

BIO ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
18.4464%
17.713%
16.6368%
16.0296%
15.523%
15.451%
13.8391%
14.2111%
13.5058%
12.37%
11.79%
11.1871%
11.2881%
11.3423%
10.8431%
11.6416%
12.9529%
13.6134%
14.2994%
14.3653%
14.2264%
14.1278%
14.1957%
14.4525%
14.616%
15.0757%
15.0577%
13.0385%
11.7009%
10.0681%
8.1887%
9.171%
9.4225%
7.3044%
8.6285%
8.5028%
8.9692%
11.461%
11.0074%
12.1841%
11.9472%
12.2587%
12.1032%
11.2463%
11.4875%
11.9758%
32.4301%
-24.8776%
-7.1826%
12.5488%
10%
24.6048%
21.632%
17.0435%
10.2821%
23.2262%
18.9399%
14.403%
9.3281%
21.8045%
17.8947%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.